Tag: bioequivalence

7 April 2026 12 Comments Maya Tillingford

Biosimilars vs Generics: Key Differences Explained

Learn the critical differences between biosimilars and generics, from how they are manufactured in labs vs. living cells to their impact on your healthcare costs.

16 December 2025 14 Comments Maya Tillingford

Clinical Outcomes After NTI Generic Switches: What Studies Show

Studies show that switching generic versions of NTI drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in drug levels. Even small changes can cause seizures, rejection, or bleeding. Know your drug, monitor closely, and ask for the brand if you're stable.